In This Section

Home / Learn / eLearning
ACCC eLearning


The Association of Community Cancer Centers (ACCC) new eLearning platform provides multidisciplinary education and resources that support the delivery of quality cancer care. With a variety of flexible online learning options that fit individual learning preferences, you can take your professional development to the next level through in-depth courses or gain quick knowledge in shorter learning formats.

The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities.

Getting started is easy. Use the same credentials that you've been using to log in to the ACCC website. If you do not have a login, you can create a new profile by clicking on "Reset Password" on the login page.

Get Started

Course Topics

ACCCeLearning offers you courses based on topics most relevant to your professional development needs. Login today to find courses critical to the delivery of cancer care under the following topics:

  • Continuing Education
  • Disease-Specific Education
  • Financial Advocacy
  • Immunotherapy
  • Patient-Centered Care
  • Precision Medicine
Browse our library for an array of courses under these topics, including:


Financial Advocacy Boot Camp. This program covers the fundamentals of oncology financial advocacy with a targeted focus on navigating today’s complex, fragmented healthcare system.

ASCO DIRECT™ HIGHLIGHTS condense the most cutting-edge science and education from the world’s premier oncology event, the ASCO Annual Meeting. The abstracts chosen for presentation and discussion reflect state-of-the-art developments and recent advances in oncology that will directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty place abstract findings into clinical context and discuss how the results may change the current standard of care.

Optimizing Outcomes for Urothelial Carcinoma. With the addition of immunotherapy and other novel targeted agents to the treatment armamentarium for advanced bladder cancer, the care landscape for urothelial carcinoma is evolving. Keep the entire multidisciplinary care team up-to-date with information and resources from the ACCC education program on Optimizing Outcomes for Urothelial Carcinoma in the Community Setting. Two options for participation: a live, on-site learning workshop or as an audio-guided web course.

The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma. This CME, CNE, and CPE-accredited educational program is designed to provide all members of the multidisciplinary care team knowledge and resources to successfully address practical issues and barriers faced in integration of immunotherapies into the treatment of renal cell carcinoma (RCC). The program will be presented in two formats: a live, on-site learning workshop and an audio-guided online course.

Case Studies in IO: A Closer Look at Care Delivery. Second in an education series, this program is organized around four case studies, the discussion will focus on current clinical evidence for optimal selection of immunotherapy and use of combination therapy. Topics covered include monitoring for and managing irAEs, care coordination and communication with non-oncology specialists, and assessment of institution- or practice-specific gaps in IO integration. Shared decision-making, reimbursement, and survivorship will also be discussed.

In Patient Reported Outcomes in Immuno-Oncology , hear experts in the field discuss the basics of patient-reported outcomes (PROs), how PROs can be integrated into IO clinical care, and how PROs can be used in IO clinical trials. Patient-reported outcomes (PROs) are a critical piece for the cancer care team in assessing the health of a patient and the effect of treatments. PROs are particularly relevant in the rapidly evolving landscape of immuno-oncology (IO) due to variability of immune-related toxicities and potential for late and long-term effects.